Top Markets
Coin of the day
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock

Polaryx Therapeutics, Inc. Common Stock

PLYX
Rang in Aktien #21586
Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to... Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions. Its developmental pipeline includes a trio of promising candidates: PLX-100, which combines PLX-200 with an ancillary supplement, targeting late infantile neuronal ceroid lipofuscinosis (LINCL) and related forms of NCL. PLX-200, a repurposed compound already utilized to address various diseases in both adult and pediatric populations. And PLX-300, derived from an edible plant, which works by activating PPARa to enhance the production of transcription factor EB. The company, established in 2014, maintains its base of operations in Paramus, New Jersey.
Aktienkurs
$2.10
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$104.43M
Veränderung (1 Tag)
-2.10%
Veränderung (1 Jahr)
-
Land
US
Handel Polaryx Therapeutics, Inc. Common Stock (PLYX)

Kategorie

Preis PLYX mit Marktkapitalisierung von B
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
PLYX
$2.10
Marktkapitalisierung von Polaryx Therapeutics, Inc. Common Stock(PLYX)
Marktkapitalisierung: $104.43M
Mit Stand August 2026 hat Polaryx Therapeutics, Inc. Common Stock eine Marktkapitalisierung von $104.43M. Das macht Polaryx Therapeutics, Inc. Common Stock laut unseren Daten zum 21586th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Polaryx Therapeutics, Inc. Common Stock von 2026 bis 2026
PLYX im Vergleich zu den Top 5 der beliebtesten stocks
Preis für PLYX Vermögenswert B Marktkapitalisierung von B Ergebnisse
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
$104,550 $104.43M
$5.211T +4,990,345.79%
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
$91,216.26 $104.43M
$4.547T +4,353,897.93%
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
$83,507.08 $104.43M
$4.162T +3,985,918.08%
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
$72,078.12 $104.43M
$3.593T +3,440,383.24%
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
$56,029.90 $104.43M
$2.793T +2,674,358.16%